*Blastocystis*, an enteric protist, is commonly found in humans and many animal species \[[@b1-kjp-58-2-181]--[@b3-kjp-58-2-181]\]. Although *Blastocystis* can be found in asymptomatic individuals, a number of studies have shown that *Blastocystis* can cause gastrointestinal symptoms, such as constipation, diarrhea, flatulence, and abdominal pain \[[@b4-kjp-58-2-181]--[@b6-kjp-58-2-181]\]. Extraintestinal manifestations such as chronic urticaria may be also associated with the presence of *Blastocystis* \[[@b6-kjp-58-2-181]\]. *Blastocystis* was listed in the Water, Sanitation, and Health programs of the World Health Organization in 2008 \[[@b7-kjp-58-2-181],[@b8-kjp-58-2-181]\].

So far, different morphological forms of *Blastocystis* exist, such as vacuolated (VF), granular (GF), amoebic (AF), and cystic (CF) forms have been reported \[[@b9-kjp-58-2-181]\]. Of these forms, the robust cystic form is known to transmit infection, and the fecal-oral route is a major mode of transmission \[[@b9-kjp-58-2-181],[@b10-kjp-58-2-181]\].

Polymerase chain reaction (PCR)-based methods using feces or fecal culture have been developed for the diagnosis of *Blastocystis* infection. Also, subtyping based on the small subunit rRNA gene (SSU-rRNA) has enabled the identification of 26 distinct *Blastocystis* subtypes (STs) in humans and animals \[[@b11-kjp-58-2-181]--[@b13-kjp-58-2-181]\]. Ten subtypes (ST1 to ST9 and ST12) have been identified in humans \[[@b14-kjp-58-2-181],[@b15-kjp-58-2-181]\]. Some of these subtypes have been also reported in animals, such as ST3, ST5, ST7, and ST8, suggesting their zoonotic potential \[[@b16-kjp-58-2-181],[@b17-kjp-58-2-181]\].

The llama (*Lama glama*) and alpaca (*Vicugna pacos*) are 2 domestic species of South American camelids \[[@b18-kjp-58-2-181]\]. *Blastocystis* was isolated for the first time from a llama in 1993 \[[@b19-kjp-58-2-181]\]. However, limited information is available regarding the prevalence and genetic diversity of *Blastocystis* in the New World camelids. Therefore, this study was performed to determine the prevalence and genotypes of *Blastocystis* in alpacas in Shanxi Province, northern China.

During August to October 2018, a total of 366 fresh fecal samples were collected from 2 counties (305 from Yangqu county and 61 from Dai county) in Shanxi Province. Each fecal specimen was obtained individually from each animal. This work was approved by the Animal Administration and Ethics Committee of Lanzhou Veterinary Institute, Chinese Academy of Agricultural Sciences (Approval No. LVRIAEC- 2018--006). The sampled animals were handled humanely in strict accordance with the requirements of the Animal Ethics Procedures and Guidelines of the People's Republic of China.

All collected fecal specimens were kept in sterile centrifuge tubes containing 2.5% potassium dichromate. Information about the sampling location, sampling date and sex of the animals have been also gathered. Genomic DNA isolation was performed using the commercial E.Z.N.A.^®^ Stool DNA Kit (Omega, Bio-tek Inc., Norcross, Georgia, USA) as per the manufacturer's specifications. DNA extracted from each sample was stored at −20°C until used for nucleic acid amplification.

PCR method based on the amplification of approximately 600 bp fragment within the small subunit ribosomal RNA (SSU rRNA) of *Blastocystis* was carried out using primers BLF (5′-ATCTGGTTGATCCTGCCAGT-3′) and BLR (5′-GAGCTTTTTAACTGCAACAACG-3′). PCR mix (25 μl) included 10×PCR buffer (Mg^2+^ free), 0.2 mM of each dNTP, 2 mM of MgCl~2~, 1.25 U of rTaq DNA polymerase, 2 μl of DNA template and 0.4 μM of each primer. Each PCR run included a positive control and a negative control. The amplification program consisted of a pre-heating denaturation step (94°C for 5 min), followed by 30 cycles of denaturation (94°C for 45 sec), annealing (57°C for 45 sec) and extension (72°C for 1 min). A final elongation step was carried out at 72°C for 10 min. The PCR products were checked by 2% agarose gel containing ethidium bromide and visualized with UV light. All the PCR amplicons with the expected size were purified and submitted to Sangon Biotech Co. Ltd (Shanghai, China) for sequencing.

Nucleotide sequences obtained in this study were subjected to BLAST searches (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). The software Clustal×1.83 was used to align the generated DNA consensus sequences with reference sequences of known *Blastocystis* subtypes downloaded from GenBank to determine *Blastocystis* subtypes. Phylogenetic analysis was carried out using Bayesian inference. The representative sequences in this study have been submitted to GenBank under the following accession numbers: MN382282-MN382284, MN382334-MN382337, and MN382339. Differences in infection rates in different regions and gender groups were analyzed by Chi-square (χ^2^) test with the software SPSS 20.0 (IBM, Chicago, Illinois, USA), and the *P*-value\<0.05 was considered statistically significant.

Our data provided the first report on the presence of *Blastocystis* in fecal samples of alpacas in Shanxi Province, northern China. Out of the 366 fecal samples tested, 87 (23.8%, 95% confidence interval \[CI\]: 19.4--28.1) were tested PCR-positive for *Blastocystis* ([Table 1](#t1-kjp-58-2-181){ref-type="table"}). *Blastocystis* was detected in samples from the 2 investigated counties. The *Blastocystis* prevalence in Dai county (14.8%, 95% CI: 5.9--23.7) was lower than that in Yangqu county (25.6%, 95% CI: 20.7--30.5), but the difference was not statistically significant (*P*\>0.05). It is difficult to explain the reasons resulting in this difference, it may be related to different stocking density, usage of medication and contact with contagium. However, there was significant difference (*P*\<0.01) in the prevalence of *Blastocystis* between male 33.7% (95% CI: 24.0--43.4) and female 20.4% (95% CI: 15.7--25.2) alpacas. Gender-related differences in the subtype distribution of *Blastocystis* have been also previously reported. For example, ST3 was found to be more common in men than in women in Sweden \[[@b20-kjp-58-2-181]\]. Given the significant difference in *Blastocystis* prevalence between male and female alpacas, we were also interested in testing whether there were any gender differences in the occurrence of ST5, ST10, and ST14. However, no statistically significant difference in the prevalence of these STs were detected.

The prevalence of *Blastocystis* in alpacas from Shanxi Province (23.8%) was lower than that reported in alpacas (85.7%), camels (50.0%), and guanacos (70.0%) in Shaanxi Province, but was similar to that in camels in Libya (24.0%) \[[@b21-kjp-58-2-181],[@b22-kjp-58-2-181]\]. Differences in the prevalence of *Blastocystis* among studies may be attributed to sample numbers since in the study of Zhao et al. included only 14 alpacas \[[@b22-kjp-58-2-181]\], whereas in the present study fecal samples were examined from 366 alpacas. The differences in prevalence may also result from variations in the geographical locations, management approaches, climatic conditions, sampling seasons, and the type of the camelids. Further epidemiological investigations of *Blastocystis* in alpacas and other camelid species should be performed in order to determine the reasons for differences in *Blastocystis* prevalence.

BLAST analysis identified 3 *Blastocystis* subtypes (namely ST5, ST10, and ST14) from alpacas in Shanxi Province. This finding was confirmed by phylogenetic analysis ([Fig. 1](#f1-kjp-58-2-181){ref-type="fig"}). The ST10 was the most dominant subtype found in animals belonging to artiodactyla, such as sheep in the UK and cattle from China, UK, Libya, and Denmark \[[@b21-kjp-58-2-181],[@b23-kjp-58-2-181],[@b24-kjp-58-2-181]\]. This fact was in agreement with our results where the ST10 was the dominant subtype and ST14 was the second highly frequent subtype. These results are also consistent with the results of previous study in alpacas from Qinling Wildlife Park in Shaanxi \[[@b22-kjp-58-2-181]\]. Interestingly, this is the first study to report the presence of *Blastocystis* ST5 in alpacas. Animals have been suggested as a reservoir for transmission of *Blastocystis* to humans largely because people can harbor identical or similar STs to the in-contact animals \[[@b16-kjp-58-2-181],[@b25-kjp-58-2-181]\]. Given the zoonotic potential of ST5 \[[@b16-kjp-58-2-181],[@b25-kjp-58-2-181]\], our results provide a new clue for the possible role of alpacas harboring *Blastocystis* ST5 in the transmission of infection to humans.

In conclusion, this study revealed 23.8% *Blastocystis* prevalence in alpacas in Shanxi Province, northern China. We also observed gender differences in *Blastocystis* prevalence. Three *Blastocystis* subtypes (namely ST5, ST10, and ST14) were identified, and ST10 was the most dominant subtype. The fact that ST5 is a potential zoonotic subtype provides support for the potential role of alpacas harboring ST5 to serve as a source for human infection with *Blastocystis*. These findings extend the current knowledge of the prevalence and subtype distribution of *Blastocystis* in alpacas. Further studies are warranted to investigate the genetic diversity of *Blastocystis* in alpacas and to elucidate the role of alpacas in zoonotic transmission of *Blastocystis* by examining samples from alpacas and their in-contact humans from other geographical region.
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Variables associated with the prevalence and subtypes of *Blastocystis* in alpacas in Shanxi Province, northern China

  Factor       Category        No. of tested   No. of positive     Prevalence % (95% CI)   OR (95% CI)[\*](#tfn1-kjp-58-2-181){ref-type="table-fn"}   *P*-value                       Subtypes (No.)
  ------------ --------------- --------------- ------------------- ----------------------- ---------------------------------------------------------- ------------------------------- --------------------------------
  Region       Yangqu County   305             78                  25.6 (20.7--30.5)       2.00 (0.9--4.2)                                            0.07                            ST5 (12); ST10 (37); ST14 (29)
  Dai County   61              9               14.8 (5.9--23.7)    Reference                                                                          ST10 (2); ST14 (7)              
                                                                                                                                                                                      
  Gender       Male            92              31                  33.7 (24.0--43.4)       1.98 (1.2--3.3)                                            \<0.01                          ST5 (3); ST10 (17); ST14 (11)
  Female       274             56              20.4 (15.7--25.2)   Reference                                                                          ST5 (9); ST10 (22); ST14 (25)   
                                                                                                                                                                                      
  Total                        366             87                  23.8 (19.4--28.1)                                                                                                  ST5 (12); ST10 (39); ST14 (36)

95% CI, 95% confidence interval; OR, odds ratio.
